This survey seeks to gain insight on trial sponsors’ perspective on offering a DTP option and their current level of awareness and understanding of any factors that may influence their ability to do so. Please take 5 minutes to share your thoughts. The first 50 qualified respondents will receive a $5 Amazon gift certificate.
Join Lash Group’s Vice President of Market Development and Strategy, Michael Craig, and Product Director of Adherence Services, Dale Hanna, as they discuss the critical nature of clinical expertise in tech-enabled patient support solutions and the importance of training teams in empathy. Register now.
The Brand Recognition Survey aims to understand current trends and address your needs. The first 50 qualified participants will be rewarded with a $10 Amazon gift card for your time and feedback. Please take 5 minutes to share your thoughts and enter for your chance to win.
For years, a debate has waged on about the distinction between an organization’s general counsel (GC) and chief ethics and compliance officer (CECO). Download this whitepaper to learn more about the role of a CECO in Life Sciences and the 10 ingredients for independence.
This research aims to understand the importance of product innovation and dose forms in driving new product design and development, consumer engagement and purchase interest for Over-the-Counter medicines. The first 50 qualified respondents will receive a $5 Amazon gift card, and all qualified respondents will be entered to win a $50 Amazon gift card. Take the survey now.
Nick Dyer ( CEO, Catalyst Clinical Research ) and Stacey Yount ( VP of Product, Trial Management Solutions, Medidata ) will discuss the industry challenges and share how Medidata’s Rave CTMS breaks down operational silos by providing a centralised solution to manage issues, deviations and associated actions. Register now.
This survey examines the main factors that motivate innovators to consider advanced dosage forms (ie: modified release, multiarticulate, ODT, etc) for the new molecules in their development pipelines, as well as how they select the most suitable technologies to create those dosage forms. The first 50 qualified respondents will receive a $5 Amazon gift card, and all qualified respondents will be entered to win a $50 Amazon gift card. Take the survey now!
Join this webinar to hear from two of Veeva’s subject matter experts, Lalana Dararutana and Serena Peirson, on ways to achieve a successful RIM implementation. Register Now!
Join this webinar to learn how Raman, NIR, and mass spectrometry provide raw material ID and bioprocess monitoring for:
- cell culture and fermentation monitoring
- moisture analysis of lyophilized materials
- near real-time discrimination of bulk protein product
Join this webinar to learn how industry leaders are using DocuSign to modernize their systems of agreement while implementing GxP validation processes. Hear best practices about how to simplify and scale your business processes while also reducing your regulatory risk.
This Fierce webinar will feature clinical trial site leaders and R&D executives, who will pass along the latest strategies for boosting site and patient enrollment in phase 1 trials. They will discuss best practices for communicating with both investigators and patients. Register now to learn more.
You’ve identified your product as a candidate for approval via the 505(b)(2) pathway and completed a successful pre-IND meeting. What comes next? Register now to find out!
In this whitepaper, UBC will show the value of standardizing diverse registry data into a common structure to assemble real-world evidence to complement ad hoc observational research. Download Now!
Understanding the existing relationships among health care professionals not only optimizes your ability to connect with them, but it also maximizes the impact of marketing communications in achieving the desired clinical behavior change that will improve patient care.
Join our webinar to learn more about how you can do more with less through “HCP Impact” strategies.
It is increasingly important for pharmaceutical brand teams to provide information about available patient savings that can help providers have full transparency into the drug prices their eligible patients are likely to pay. This infographic aims to help inform brand teams as they make critical decisions about meeting the demand for price transparency. Download Now!
Increasingly complex clinical trials place a tremendous burden on study sites, exacerbating already-troubling recruitment and enrollment issues. Overwhelmed, many sites may not be up to the task or have the appropriate infrastructure, creating costly delays that keep new therapies from patients. However, strategically placed on-the-ground resources can ease that burden, streamlining enrollment, making sites more agile and offering patients personalized attention that leads to conversion and retention. Download the whitepaper to learn more.
Register for this webinar to get insights from industry experts on:
- Demand led manufacturing and supply
- Forecasting and inventory management
- Innovations and considerations in labeling
- Direct-to-patient distribution
In this publication, Blue Latitude Health maps the journey of stakeholders impacted by the rise of precision medicine today.
Download the report for:
- Exclusive interviews with major players from patients to oncologists, healthcare systems and industry
- Industry gamechangers reveal how they are innovating in precision medicine
- Insights on the unmet needs of seven core stakeholders, as well as information on how to turn these challenges into engagement opportunities.
Join us to learn how recent enhancements to protein expression platforms can significantly increase expression levels for complex proteins. New technologies for simplifying and increasing expression levels of multi-chain and complex proteins will be presented. Register Now!
Join this webinar to learn the five characteristics of a unified platform and how each benefits clinical research both for a single trial and across your suite of research efforts. Register Now!
Modernizing the way studies are conducted can continue to evolve with the use of more accessible information. Mobile specimen collections and health data support this evolution and broaden the scope for which types of studies can be conducted virtually. Download this whitepaper to learn more.
Low patient numbers & high unmet need for rare disease treatments require manufacturers to develop an evidence package that meets all stakeholders' needs to achieve EU access. Integrated regulatory & HTA scientific advice and multi-country collaborations can help evidence planning to increase access. Download the whitepaper.
The patient’s unique perspective is critically important in rare disease research due to the existence of limited data. Learn more about what concepts to measure and what to consider in choosing a clinical outcome assessment to ensure the content is clinically relevant and important to patients. Download the whitepaper.
Patient-centricity gets a lot of buzz, but what are the benefits of involving patients in the planning of a clinical trial? This webinar looks at where in the process to get patient input, the benefits, and what tactics to use to get input. Register now.
A new, promising data source that could help explore and unlock new discoveries lies in the use of simulated data that can be used in place of real patient information. Join our experts as they provide insight on this newly emerging data source. Register Now!
Join senior leaders from Accenture and Salesforce to find out how future-focused Biopharma companies are delivering growth amid compressive disruption and leveraging that investment in digital technologies by embracing New Science to drive value for the healthcare ecosystem, including, and most importantly, to raise the standard of care for their patients. Register Now!
Join this webinar and learn strategies designed to help improve financial health, fuel innovation and increase compliance by combining automated clinical finance solutions and industry best practices. Register Now!
Glean insight into a customer-engagement platform that includes solutions for monetizing website traffic, detailed user analytics, and other tools. Provide your company with an innovative and intuitive platform for bringing consumers directly to a point of sale. Register Now!
To bring a new drug to market, it can take more than a decade and cost upwards of $1 billion. What if there were a way to address global patient needs faster, less expensively, and with better outcomes? Register Now!
During this webinar, Thermo Fisher Scientific's Kaspar van den Dries and Helena Teles will discuss potential mechanisms of increased absorption with lipid formulations and appropriate screening tools that are used during the development approach of these formulations. Register Now!
If your company is looking to adopt a new eCOA solution or have issues with your current one, this webinar is a must attend. Companies of all sizes will be able to learn from how Celgene made the case internally for change by redefining their implementation strategy for collection of clinical outcome assessment data (eCOA). Register now!
Registries provide crucial data to better understand a disease and plan more effective real-world studies. Learn about disease & treatment registries’ benefit. Download the whitepaper.
This webinar will address challenges encountered when leveraging Real-World Evidence such as finding the “right” data set, identifying high priority use cases to show quick wins, and creating integrated evidence plans across a product’s lifecycle. Register Now!
The number of pediatric drug approvals has increased 5 fold over the last 20 years, rising from 10-20 approvals per year to 50-60 annually today. Increased awareness around pediatric medicine and FDA support for pediatric clinical research are just some of the factors contributing to this growing market. Register Now!
Meeting the rapid changes in technology and patient expectations has become a hard pill to swallow. In this report, see how they are adapting, and discover the top 4 trends redefining the industry. Get the report today.
Proven Expertise. Flexible Solutions. Right Scale. Visit us during CPhI NA, Booth 1206, April 30 - May 2 in Chicago Illinois. Schedule 1:1 meetings with our experts, visit our speaking presentations, and learn about our new spray drying capabilities and our Integrated offerings designed to accelerate, simplify and de-risk your complex small and large molecule products. Discover how we can help solve your biggest drug development, delivery and supply challenges.
Expert Speaker Presentations:
- Building a Better Drug: Strategies to Enhance Patient Drug Regimen
- Advancements in Manufacturing Solutions
Visit us at CPhI NA, Booth #812. CMIC is the first and the largest CRO in Japan, with expended capabilities for contract development and manufacturing as a CDMO. Click here to schedule a meeting and learn more about how we can help you to bridge your drug development and commercialization needs between the U.S. and Japan.
- Formulation development for oral, injectable, and topical
- CMC analytical expertise
- Advanced manufacturing technologies
- Commercial packaging platform
This webinar will discuss development considerations for CBD and other cannabis-derived products from a clinical, preclinical (pharmacology/toxicology), CMC, and regulatory perspective. Register now.
During this webinar, PwC’s Health Research Institute will review findings from a new global survey of industry executives, and provide analysis and commentary on key drug pricing issues. Register Now!
Selecting a device partner for combination product development should be based on several key considerations. This webinar will provide insights into the elements that guide the selection of a device partner, including a proposed approach that consists of a quantitative assessment of risks and benefits.
Patient engagement is essential in R&D and disease management. Many life science companies talk about yet are still searching for ways to deliver on their patient-centric missions. This webinar presents a proven model to embed patient-centricity into your company’s DNA. Register Now.
The market for orally disintegrating tablets (ODT) has grown annually and is projected to reach US$21B in 2023. Attend this complimentary webinar on patient-centric drug development and advanced ODT technologies in Japan and the US. Register now!
Join this webinar to discover the advantages of using Signatera™ (RUO), a novel assay custom-designed for each patient that detects circulating tumor DNA (ctDNA) with high sensitivity and specificity to monitor molecular residual disease, early recurrence, and treatment response across solid tumors. Register Now!
In this webinar, we will review the current OTC remedies for cough, cold and allergy categories and discuss strategies to grow your share on shelf space with innovative dosage forms.
Technology is impacting every aspect of our lives, and the life sciences industry is no different—it is changing the way companies operate. The need to embrace change is an imperative for these companies to stay competitive and continue to deliver on patient needs. Register Now!
To achieve adaptable and scalable trial execution, a mindset change and more flexible approach to data management is necessary. Join this webinar to hear industry experts discuss three key lessons learned when applying Agile Development Methodology principles into your work in data management.
Join Dr. David Gosalvez to see how R&D productivity can be improved in three critical areas: Lead Discovery, Screening and data capture. Register Now!
Serialization is a great achievement for our industry. However, most executives now realize that it is only part of the solution and serialization alone cannot solve the escalating problems of counterfeiting and diversion within the Pharmaceutical industry.
In this webinar we will discuss going beyond serialization and understanding why it’s not enough and the need to stay innovative and add value and protection to your current solutions. Register now.
Learn how companies use the cloud to optimize clinical trial designs and analyze real-world data and how cloud-based artificial intelligence and machine learning are clearing the patient enrollment bottleneck. Download this whitepaper.
“Biologics manufacturing can be much riskier because it requires far more planning, investment and experienced personnel to carry it out,” says Jennifer Cannon, the new Vice President, Commercial Operations Development at AbbVie Contract Manufacturing. “Biologics are temperature and light sensitive, susceptible to shearing and degradation, and not as durable and robust as small molecules.” It is therefore critical to have the right manufacturing partner to minimize challenges as a therapy moves from discovery to commercialization.